Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress, Circulation, vol.99, pp.2951-2957, 1999. ,
Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin, Circulation, vol.102, pp.351-356, 2000. ,
Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure, Circulation, vol.114, pp.2498-2507, 2006. ,
Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure, Cardiovasc Res, vol.25, pp.438-440, 1991. ,
Endotheliumdependent vasodilation is attenuated in patients with heart failure, Circulation, vol.84, pp.1589-1596, 1991. ,
Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide, J Am Coll Cardiol, vol.28, pp.585-590, 1996. ,
Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure, Hypertension, vol.30, issue.1, pp.50-56, 1997. ,
Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure, Circulation, vol.111, pp.310-314, 2005. ,
Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death, Eur Heart J, vol.26, pp.65-69, 2005. ,
Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease, J Mol Cell Cardiol, vol.73, pp.80-91, 2014. ,
Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure, Hypertension, vol.38, pp.1446-1450, 2001. ,
Vascular actions of aldosterone, J Vasc Res, vol.50, pp.89-99, 2013. ,
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, vol.109, pp.1674-1679, 2004. ,
Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia, J Cardiovasc Pharmacol, vol.59, pp.260-267, 2012. ,
PTP1B: a simple enzyme for a complex world, Crit Rev Biochem Mol Biol, vol.48, pp.430-445, 2013. ,
Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B, J Mol Cell Cardiol, vol.52, pp.1257-1264, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00801304
Neuronal PTP1B regulates body weight, adiposity and leptin action, Nat Med, vol.12, pp.917-924, 2006. ,
Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance, J Immunol, vol.176, pp.6503-6511, 2006. ,
Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization, Arterioscler Thromb Vasc Biol, vol.29, pp.1543-1550, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00410359
Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone, Circ Res, vol.105, pp.1013-1022, 2009. ,
Deletion of protein tyrosine phosphatase 1B (PTP1B) enhances endothelial cyclooxygenase 2 expression and protects mice from type 1 diabetes-induced endothelial dysfunction, PLoS One, vol.10, p.126866, 2015. ,
Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction, Biochem Pharmacol, vol.92, pp.607-617, 2014. ,
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade, Br J Pharmacol, vol.139, pp.1317-1325, 2003. ,
Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction, Circ Res, vol.107, pp.923-933, 2010. ,
Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice, FASEB J, vol.28, pp.3351-3361, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02142777
PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells, Circulation, vol.130, pp.902-909, 2014. ,
Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice, Proc Natl Acad Sci U S A, vol.100, pp.4891-4896, 2003. ,
Cardiomyocyterestricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction, Circulation, vol.110, pp.2666-2672, 2004. ,
Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice, J Am Heart Assoc, vol.4, 2015. ,